Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • General Inquiries
  • Worldwide Offices
  • Request More Information
  • Journalists

Industry Congregates at the Second Edition of PharmaLytica 2015


News provided by

UBM India Pvt. Ltd.

02 Sep, 2015, 17:15 IST

Share this article

Share toX

Share this article

Share toX

L-R: Mr. Yogesh Mudras, Acting Managing Director - UBM India, Dr. P V Appaji, Director General, Pharmexcil, Shri. Madan Mohan Reddy, Vice-Chairman, Pharmexcil, Hyderabad & Whole-time Director âeuro" Aurobindo Pharma & Shri M. Amrutha Rao, Director & Licensing Authority, Drug Control Administration at PharmaLytica 2015 at HITEX (PRNewsFoto/UBM India Pvt. Ltd.)
L-R: Mr. Yogesh Mudras, Acting Managing Director - UBM India, Dr. P V Appaji, Director General, Pharmexcil, Shri. Madan Mohan Reddy, Vice-Chairman, Pharmexcil, Hyderabad & Whole-time Director âeuro" Aurobindo Pharma & Shri M. Amrutha Rao, Director & Licensing Authority, Drug Control Administration at PharmaLytica 2015 at HITEX (PRNewsFoto/UBM India Pvt. Ltd.)
Mr. Yogesh Mudras, Acting Managing Director - UBM India handing over the bouquet to Dr. P V Appaji, Director General, Pharmexcil (PRNewsFoto/UBM India Pvt. Ltd.)
Mr. Yogesh Mudras, Acting Managing Director - UBM India handing over the bouquet to Dr. P V Appaji, Director General, Pharmexcil (PRNewsFoto/UBM India Pvt. Ltd.)
Second edition of PharmaLytica to be held at HITEX, Hyderabad on 2-3 September 2015. (PRNewsFoto/UBM India Pvt. Ltd.)
Second edition of PharmaLytica to be held at HITEX, Hyderabad on 2-3 September 2015. (PRNewsFoto/UBM India Pvt. Ltd.)
UBM India Logo (PRNewsFoto/UBM India  Pvt. Ltd.)
UBM India Logo (PRNewsFoto/UBM India Pvt. Ltd.)

HYDERABAD, India, September 2, 2015 /PRNewswire/ --

- India's Most Comprehensive Analytical and Contract Service Event in the Pharmaceutical Capital of India, Hyderabad 

- Over 100 Participating Exhibitors From all Over India  

- Industry-Focussed Conference With key Experts 

UBM India, organisers of CPhI / P-MEC India, the world's leading pharma trade show and conference, today hosted the 2nd edition of PharmaLytica 2015. The two-day event was inaugurated today by Madan Mohan Reddy, Vice-Chairman, Pharmexcil, Hyderabad & Whole-time Director - Aurobindo Pharma, Dr. P V Appaji, Director General, Pharmexcil, Hyderabad, Shri M. Amrutha Rao, Deputy Director & Licensing Authority, Drug Control Administration and Yogesh Mudras, Acting Managing Director - UBM India, at the HITEX Exhibition Center.

     (Photo: http://photos.prnewswire.com/prnh/20150902/10129471-a )
     (Photo: http://photos.prnewswire.com/prnh/20150902/10129471-b )
     (Logo: http://photos.prnewswire.com/prnh/20150831/10129340 )
     (Logo: http://photos.prnewswire.com/prnh/20130226/599595-c )


Backed by our proven expertise of growing businesses in India's pharma sector, PharmaLytica has been able to create an ideal platform in the rich and conducive pharmaceutical capital of India, Hyderabad, which is considered to be the best bulk drug hub in India and accounts for nearly a fifth of India's exports of drugs.

The 2nd edition of PharmaLytica this year had over 100 exhibitors across analytical, contracting, biotechnology and quality control sectors, including key companies like Airpac Filters & Systems Pvt. Ltd., Eureka Forbes Ltd., Gandhi Automations Pvt. Ltd., GD Lab Solutions Pvt. Ltd., Hydranautics - A Nitto Group Company, Kleantech Engineering Systems Pvt. Ltd., Machinfabrik Industries Pvt. Ltd., Mack Pharmatech Pvt. Ltd., Naanolab India, Newtronic Lifecare Equipment Pvt. Ltd., Ozone Overseas Pvt. Ltd., Prism Pharma Machinery, Protech Technologies Pvt. Ltd., Schott Kaisha Private Limited, Symed Labs Ltd., Tempo Instruments Pvt. Ltd., Nirakara Industries, Labtop Instruments, Hydropure and Anatek Services amongst others.

Yogesh Mudras, Acting Managing Director, UBM India, said, "Analytical and outsourcing services in India is set for a huge augmentation owing to quality, research, regulatory and environmental compliances. Consequently, the need of the hour for Indian industry players is to optimise the potential of today's landscape with better product and service offerings. To further market these offerings to a wider audience and in-turn stimulate trade amongst this niche pharma sector, UBM India brings the 2nd edition of PharmaLytica, an industry platform dedicated to analytical, outsourcing, laboratory, scientific & biotechnology sector."

Dr. PV Appaji, Director General - Pharmexcil, said, "I express my sincere thanks to UBM India for organising the second edition of PharmaLytica in Hyderabad. One-third of pharma production is from Telangana and Andhra Pradesh states and large number of API and Formulations facilities are located in the region. Pharma companies who are engaged in drug testing, quality control and quality assurance should utilise this opportunity of meeting various exhibitors at PharmaLytica event. The companies should understand about the latest machinery, instrumentation and improved analytical techniques which will further enable them to implement quality testing methodologies and bring cost efficiencies, thus leading to increase in exports from India."

The Innovation Gallery and the Brand India Pavilion by Pharmexcil were the main highlights of the show. The event was also marked by a conference with industry deliberations by key experts such as, Venkat Manohar, Director, IICMS; G Sundar, Director, Pharmaqa Compliance Services; Rajni Jha, Independent Consultant; Sumathi Rao, Head - Analytical, Aurobindo Pharma and Vasudev Jakhaniya, Head - Trace Analytical Lab. Some of the topics of discussion on the first day included:

  • Strategies on preventing the regulatory deficiencies, addressing dossier review deficiencies, strategies on avoiding and handling deficiencies
  • Latest methods of analytical techniques for quantification of extractables and leachables
  • Assessment and control of DNA reactive (mutagenic) impurities to limit potential carcinogenic risk through redefining processes and CMC controls
  • Quality by design in pharmaceutical analysis
  • Elemental impurities ICH Q3D: Scope, applicability and implications, link between EP & USP monographs and authority expectation

About UBM India 

UBM India is India's leading exhibition organizer that provides the industry with platforms that bring together buyers and sellers from around the world, through a portfolio of exhibitions, content-led conferences & seminars. UBM India hosts over 25 large-scale exhibitions and 40 conferences across the country every year; thereby enabling trade across multiple industry verticals. A UBM Asia Company, UBM India has offices across Mumbai, New Delhi, Bangalore and Chennai. UBM Asia is owned by UBM plc, which is listed on the London Stock Exchange. UBM Asia is the leading exhibition organizer in Asia and the biggest commercial organizer in mainland China, India and Malaysia. For further details, please visit: http://www.ubmindia.in

Media Contact:

Priya Badshah
[email protected]
UBM India Pvt. Ltd.

Hari Prasad
[email protected]
+91-9618883774
MSL Group

Modal title

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.